ASR vs CNM

ASR exhibits strong financial health with a Piotroski F-Score of 7/9, indicating solid operational and balance sheet strength. Profitability metrics are robust, with high margins and ROE above sector average, while leverage remains low. However, recent earnings declines and poor earnings surprise trends—four consecutive misses with double-digit negative surprises—raise concerns about near-term execution. The stock trades significantly above the Graham Number of $64.05, reflecting premium valuation despite weak earnings growth, though it aligns more closely with the growth-based intrinsic value of $181.09.

CNM exhibits strong operational health with a Piotroski F-Score of 7/9, indicating robust financial stability and efficiency. However, the stock is currently trading at $49.50, which is slightly above its growth-based intrinsic value of $47.70 and significantly above its defensive Graham Number of $23.45. While earnings are growing (9.10% YoY), the company is facing a concerning trend of declining revenues (-6.90% YoY), suggesting a reliance on cost-cutting rather than organic expansion. Technical trends and insider sentiment are currently bearish, offsetting the optimistic analyst target of $60.88.